Medicus Pharma Ltd. announced that it will receive $11,017,500 in funding on May 3, 2024. The company will issue common shares, non-convertible debt and option, warrant or other right to acquire another security in the transaction. The minimum investment accepted from any outside investor is $25,000.

The company will issue securities pursuant to exemption provided under Regulation D.